Acetylsalicylic acid resistance in patients with Type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease

Cetin, Mustafa; Kiziltunc, EMRULLAH; Cetin, Zehra; Cicekcioglu, Hulya; Sahin, Muslum; Isik, Serhat; Kurtul, Alparslan; Ornek, Ender; Ulusoy, Feridun

doi:10.12669/pjms.303.4773

Acetylsalicylic acid resistance in patients with Type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease

Cetin M., Kiziltunc E., Cetin Z. G., Cicekcioglu H., Sahin M., Isik S., ...Daha Fazla

PAKISTAN JOURNAL OF MEDICAL SCIENCES, cilt.30, sa.3, ss.539-544, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 30 Sayı: 3
Basım Tarihi: 2014
Doi Numarası: 10.12669/pjms.303.4773
Dergi Adı: PAKISTAN JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.539-544
Gazi Üniversitesi Adresli: Hayır

Özet

Objective: Several studies have demonstrated the beneficial role of antiplatelet therapy with acetylsalicylic acid (ASA) at atherosclerotic vascular disease. Antiaggregant effect of ASA is not uniform in all patients. Purpose of the present study is to evaluate the prevalence of ASA resistance in patients with type 2 diabetes mellitus (T2DM), pre-diabetes and non-diabetic coronary artery disease (CAD).